CIK 0001798749
- Emerging growth company
Jade Biosciences, Inc.
Sign in to watch- Ticker
- JBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831377888
- Phone
- +1 781-312-3013
- Business address
- 221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aerovate Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-01 | Verwijs Marinus CHIEF TECHNOLOGY OFFICER | Sale | −970 | $10.46 | $10K | 0 |
| 2023-11-01 | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,092 | $10.42 | $11K | 0 |
| 2023-09-07 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +30 | $2.14 | $64 | 1,321 |
| 2023-09-07 | Dake Benjamin T SEE REMARKS | Sale 10b5-1 | −30 | $15.01 | $450 | 1,291 |
| 2023-09-07 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30 | 150,226 | ||
| 2023-09-06 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +2,413 | $1.74 | $4K | 3,704 |
| 2023-09-06 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +1,518 | $2.14 | $3K | 5,222 |
| 2023-09-06 | Dake Benjamin T SEE REMARKS | Sale 10b5-1 | −3,931 | $15.06 | $59K | 1,291 |
| 2023-09-06 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −906 | 3,622 | ||
| 2023-09-06 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,507 | 16,575 | ||
| 2023-09-06 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,018 | 19,350 | ||
| 2023-09-06 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −500 | 150,256 | ||
| 2023-08-07 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +2,412 | $1.74 | $4K | 3,703 |
| 2023-08-07 | Dake Benjamin T SEE REMARKS | Option exercise 10b5-1 | +7,871 | $2.14 | $17K | 11,574 |
| 2023-08-07 | Dake Benjamin T SEE REMARKS | Sale 10b5-1 | −9,742 | $15.48 | $151K | 1,832 |
| 2023-08-07 | Dake Benjamin T SEE REMARKS | Sale 10b5-1 | −541 | $16.25 | $9K | 1,291 |
| 2023-08-07 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −905 | 4,528 | ||
| 2023-08-07 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,507 | 18,082 | ||
| 2023-08-07 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,018 | 20,368 | ||
| 2023-08-07 | Dake Benjamin T SEE REMARKS | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,853 | 150,756 |
Page 13 of 16 · 315 trades